|
ZNF101 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.938000E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.826100E-02 |
| Normal-vs-Stage2 |
5.252200E-01 |
| Normal-vs-Stage3 |
9.119900E-02 |
| Normal-vs-Stage4 |
1.382390E-01 |
| Stage1-vs-Stage2 |
3.386200E-01 |
| Stage1-vs-Stage3 |
8.205200E-01 |
| Stage1-vs-Stage4 |
5.782000E-01 |
| Stage2-vs-Stage3 |
3.597400E-01 |
| Stage2-vs-Stage4 |
3.378800E-01 |
| Stage3-vs-Stage4 |
7.309000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.301900E-02 |
| Normal-vs-AfricanAmerican |
2.302200E-01 |
| Normal-vs-Asian |
2.620400E-01 |
| Caucasian-vs-AfricanAmerican |
2.266200E-01 |
| Caucasian-vs-Asian |
8.381400E-01 |
| AfricanAmerican-vs-Asian |
5.267000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.979720E-02 |
| Normal-vs-Female |
2.834600E-01 |
| Male-vs-Female |
1.308360E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.471900E-02 |
| Normal-vs-Extreme_Weight |
1.188260E-02 |
| Normal-vs-Obese |
1.842610E-01 |
| Normal-vs-Extreme_Obese |
2.950100E-02 |
| Normal_Weight-vs-Extreme_Weight |
9.177600E-01 |
| Normal_Weight-vs-Obese |
3.144800E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.911400E-01 |
| Extreme_Weight-vs-Obese |
1.588810E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.243400E-01 |
| Obese-vs-Extreme_Obese |
1.076640E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.235210E-01 |
| Normal-vs-Age(41-60Yrs) |
3.028600E-01 |
| Normal-vs-Age(61-80Yrs) |
9.998900E-03 |
| Normal-vs-Age(81-100Yrs) |
3.277400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.740800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.035200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.160120E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.844500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.980700E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.628100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.600000E-02 |
| Normal-VS-Type2 PRCC |
1.380470E-02 |
| Normal-VS-KIRP CIMP |
6.827600E-01 |
| Normal-VS-Unclassified PRCC |
5.002600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.036640E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.103600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.161400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.414400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.452400E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
9.591000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.843200E-03 |
| Normal-vs-N1 |
6.007600E-01 |
| Normal-vs-N2 |
1.386410E-02 |
| N0-vs-N1 |
1.134180E-01 |
| N0-vs-N2 |
6.488300E-02 |
| N1-vs-N2 |
5.104100E-02 |
|
|
